Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors

Clare E. Murray,Anand V. R. Kornepati,Carlos Ontiveros,Yiji Liao,Bárbara de la Peña Avalos,Cody M. Rogers,Zexuan Liu,Yilun Deng,Haiyan Bai,Suresh Kari,Alvaro S. Padron,Jacob T. Boyd,Ryan Reyes,Curtis A. Clark,Robert S. Svatek,Rong Li…
DOI: https://doi.org/10.1186/s12943-024-02147-z
IF: 37.3
2024-10-31
Molecular Cancer
Abstract:Aside from the canonical role of PDL1 as a tumour surface-expressed immune checkpoint molecule, tumour-intrinsic PDL1 signals regulate non-canonical immunopathological pathways mediating treatment resistance whose significance, mechanisms, and therapeutic targeting remain incompletely understood. Recent reports implicate tumour-intrinsic PDL1 signals in the DNA damage response (DDR), including promoting homologous recombination DNA damage repair and mRNA stability of DDR proteins, but many mechanistic details remain undefined.
oncology,biochemistry & molecular biology
What problem does this paper attempt to address?